Sharps Technology Long Term Debt 2022-2025 | STSS

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Sharps Technology long term debt from 2022 to 2025. Long term debt can be defined as the sum of all long term debt fields.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Sharps Technology long term debt from 2022 to 2025. Long term debt can be defined as the sum of all long term debt fields.

Related Stocks
Company Name	Market Cap
Abbott Laboratories (ABT)	$230.9B
Boston Scientific (BSX)	$156.3B
Stryker (SYK)	$149.6B
EssilorLuxottica (ESLOY)	$141.3B
Medtronic (MDT)	$119B
Lonza Group Ag (LZAGY)	$49.8B
Haleon (HLN)	$44B
ResMed (RMD)	$40.2B
Agilent Technologies (A)	$35.7B
GE HealthCare Technologies (GEHC)	$33.7B
Terumo (TRUMY)	$26.6B
Koninklijke Philips (PHG)	$26.6B
Insulet (PODD)	$23.9B
Zimmer Biomet Holdings (ZBH)	$21B
Smith & Nephew SNATS (SNN)	$16.4B
Baxter (BAX)	$12.7B
Sunny Optical Technology (SNPTF)	$10.8B
Demant (WILYY)	$8.1B
Bio-Rad Laboratories (BIO)	$8.1B
Lantheus Holdings (LNTH)	$3.7B
Envista Holdings (NVST)	$3.5B
Shandong Weigao Medical Polymer (SHWGF)	$3.5B
Prestige Consumer Healthcare (PBH)	$3.3B
Perrigo (PRGO)	$3.3B
ICU Medical (ICUI)	$3.2B
Haemonetics (HAE)	$2.6B
Acuren (TIC)	$2.3B
Curaleaf Holdings (CURLF)	$2.2B
LeMaitre Vascular (LMAT)	$2.2B
QuidelOrtho (QDEL)	$1.9B